India’s COVID vaccine maker urges Biden to lift exports embargo | Coronavirus pandemic News

The Serum Institute of India, the world’s largest vaccine maker, says the U.S. embargo on the export of raw materials is affecting the production of shots.

The Serum Institute of India (SII), the world’s largest vaccine maker, has urged President Joe Biden to lift a United States embargo on the export of raw materials that is affecting the production of COVID-19 shots.

“Respect @POTUS, if we really want to unite on behalf of the vaccine industry outside of the US to fight this virus, I humbly ask you to lift the embargo on US commodity exports so that vaccine production can increase. SII chief Adar Poonawalla said in a tweet on Friday.

Dear Mr. @POTUS, If we really want to unite on behalf of the vaccine industry outside of the US to fight this virus, I humbly ask you to lift the embargo on raw material exports from the US so that vaccine production can increase. Your administration has the details. 🙏🙏

– Adar Poonawalla (adarpoonawalla), April 16, 2021

The SII makes the AstraZeneca shot, which accounts for more than 91 percent of the 115.5 million doses administered in the country. The company will shortly begin manufacturing the Novavax vaccine.

The vaccinations drop from the summit

Poonawalla’s appeal came as India’s daily COVID-19 vaccinations slowed from their peak earlier this month, while new infections set a record, government data showed on Friday.

India reported the highest number of coronavirus cases worldwide this month. With 174,308 deaths, there are a total of 14.3 million after the USA.

Amid the surge and after India administered and sold tens of millions of COVID-19 vaccine doses overseas, India was suddenly no longer faced with the drug.

It abruptly changed rules to speed up imports of vaccines after previously dismissing foreign drug manufacturers like Pfizer.

According to the government’s co-win vaccination coordination portal, vaccinations peaked at 4.5 million doses on April 5, but an average of three million a day since then.

Many vaccination centers in India are now rationing supplies despite only vaccinating people over the age of 45 after starting the campaign with frontline workers in mid-January.

It has given the most doses in the world after the US and China, but is much lower per capita.

Many states have sought to expand the vaccination campaign to all adults, but the government has indicated that the doses are “finite.”

The government said Friday the country had an inventory of about 30 million cans. According to the vaccination trend in the past week, this will be sufficient for 10 days.

India this week issued an emergency permit for the Russian vaccine Sputnik V, and imports of up to 125 million people will begin this month. The government has also asked Pfizer, Moderna, and Johnson and Johnson to sell their recordings to India.

It has also enabled the Haffkine Institute biomedical research institute in Maharashtra state to produce the home-grown shot of Covaxin as developer Bharat Biotech is struggling to ramp up its production.